about
Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adultsFactors influencing general practitioners' decisions about cardiovascular disease risk reassessment: findings from experimental and interview studies.A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.I don't believe it, but i'd better do something about it: patient experiences of online heart age risk calculators.Communicating cardiovascular disease risk: an interview study of General Practitioners' use of absolute risk within tailored communication strategies.Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial.General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study.Shared decision making in Australia in 2017.Factors influencing intention to undergo whole genome screening in future healthcare: a single-blind parallel-group randomised trial.Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer.Decision aids for breast cancer chemoprevention.Sexual adjustment following early stage cervical and endometrial cancer: prospective controlled multi-centre study.In conflict with ourselves? An investigation of heuristic and analytic processes in decision making.Heuristics and biases in cardiovascular disease prevention: How can we improve communication about risk, benefits and harms?Too much medicine in older people? Deprescribing through shared decision making.How do general practitioners and patients make decisions about cardiovascular disease risk?General practitioners' use of different cardiovascular risk assessment strategies: a qualitative study.Quantity vs. quality: an exploration of the predictors of posttreatment sexual adjustment for women affected by early stage cervical and endometrial cancer.Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?Clinical Validity, Understandability, and Actionability of Online Cardiovascular Disease Risk Calculators: Systematic Review.Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial.Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic CardiomyopathyIs the “Heart Age” Concept Helpful or Harmful Compared to Absolute Cardiovascular Disease Risk? An Experimental StudyRecruiting general practitioners as participants for qualitative and experimental primary care studies in AustraliaPrimary care physician perspectives on patient apps for type 2 diabetes self-management that link to primary care: An interview study to identify factors to support physician engagement (Preprint)Examining the information needed for acceptance of deintensified screening programmes: qualitative focus groups about cervical screening in Australia
P50
Q26796403-273EF96A-302A-4378-8485-F46D7AD9C8A6Q27313674-BDAC1DF9-07AA-4E36-A5A4-961E00595E08Q27860879-4220D7D0-DEA2-45F8-A5AD-A6C9377B44DAQ33629449-516B8669-6BB3-41E2-AFAB-CDFB91D62A64Q33633369-520DCE02-1781-46D1-A0E1-538FDA1DE9CCQ33701669-63358BB9-0CD0-43AA-AEF7-B7A0865C461BQ33877375-B28B6CFA-3C64-423B-82C5-3D6AD088AD26Q37585702-6BC6EAED-F9C1-42BA-AE78-25B79817336CQ38681483-C1E00847-E1C2-4797-8F5C-A9B589393155Q39560593-CEFE99DF-05E1-4B1C-923E-8DDFBA8E52CEQ39676635-50EBD0CA-6E18-4BB7-A6E5-B632F5684DFDQ42370187-987FA2E6-F956-4919-97C2-250C99BDAD66Q45237934-8ADD8D6A-024F-4715-A72C-6406B4CC745FQ45293432-7F31E2FB-3964-4CD8-B948-C8F550EABA69Q47300026-97B76BDC-655B-43F1-8D2F-25713DD62AD6Q47732937-EBC6FFB5-5365-4CDB-881D-A05E8E3D1DB7Q47738506-EFFDB51B-5B4F-4451-962D-8A7EE4B698E0Q47843878-5D9DC82B-C516-4D85-91A6-F154274C3591Q47970423-6BBE2E72-B7EE-49AD-838D-7C3F08644D72Q48096583-8E961653-90CD-4C71-A547-A9085D778A46Q48121213-12FC9C05-C00C-4B20-9EA5-6866CC0729D5Q49045213-6EA35B73-FB93-49B1-AF03-E89BF796A277Q57187604-BA6460DC-6AB7-4D41-A3A4-A81874E6FBD5Q57187622-F32234DF-0357-4445-AD49-A987E313ECAAQ57187627-2BB0D51F-0B4D-4196-90E0-3C4948729BA7Q59730665-C176A660-D292-488B-83E5-1052A3E8AAB2Q90823722-980FB2D0-F51C-44C6-9954-F2A9B1E5D946
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carissa Bonner
@ast
Carissa Bonner
@en
Carissa Bonner
@es
Carissa Bonner
@nl
Carissa Bonner
@sl
type
label
Carissa Bonner
@ast
Carissa Bonner
@en
Carissa Bonner
@es
Carissa Bonner
@nl
Carissa Bonner
@sl
altLabel
Bonner C
@en
prefLabel
Carissa Bonner
@ast
Carissa Bonner
@en
Carissa Bonner
@es
Carissa Bonner
@nl
Carissa Bonner
@sl
P106
P1153
52263228800
P31
P496
0000-0002-4797-6460